2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections
| Image |  |
|---|---|
| Description | scientific article published on September 2002 |
| Author/s |
author: Christine Le Roy Bahram Bodaghi Johan Neyts Lieve Naesens Dirk Daelemans Graciela Andrei Laurence Lagneaux Dominique Schols Anne Bousseau Erik De Clercq Robert Snoeck |
| Publication date | September 1, 2002 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |